CRISPR/Cas9 Market 2019 Global Trend, Segmentation And Opportunities Forecast To 2024

Wiseguyreports.Com Adds “CRISPR/Cas9 -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

CRISPR/Cas9 Industry


CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes. Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases. 

In 2018, the global CRISPR/Cas9 market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CRISPR/Cas9 development in United States, Europe and China.

The key players covered in this study 

Caribou Biosciences 
Integrated DNA Technologies (IDT) 
CRISPR Therapeutics 
Mirus Bio 
Editas Medicine 
Takara Bio 
Thermo Fisher Scientific 
Horizon Discovery Group 
Intellia Therapeutics 
Agilent Technologies 

Request for Sample Report @

Market segment by Type, the product can be split into 
Genome Editing 
Genetic engineering 
gRNA Database/Gene Librar 
CRISPR Plasmid 
Human Stem Cells 
Genetically Modified Organisms/Crops 
Cell Line Engineering

Market segment by Application, split into 
Biotechnology Companies 
Pharmaceutical Companies 
Academic Institutes 
Research and Development Institutes

Market segment by Regions/Countries, this report covers 
United States 
Southeast Asia 
Central & South America

The study objectives of this report are: 
To analyze global CRISPR/Cas9 status, future forecast, growth opportunity, key market and key players. 
To present the CRISPR/Cas9 development in United States, Europe and China. 
To strategically profile the key players and comprehensively analyze their development plan and strategies. 
To define, describe and forecast the market by product type, market and key regions.

Leave a Query @


Table of Contents

1 Report Overview 
1.1 Study Scope 
1.2 Key Market Segments 
1.3 Players Covered 
1.4 Market Analysis by Type 
1.4.1 Global CRISPR/Cas9 Market Size Growth Rate by Type (2014-2025) 
1.4.2 Genome Editing 
1.4.3 Genetic engineering 
1.4.4 gRNA Database/Gene Librar 
1.4.5 CRISPR Plasmid 
1.4.6 Human Stem Cells 
1.4.7 Genetically Modified Organisms/Crops 
1.4.8 Cell Line Engineering 
1.5 Market by Application 
1.5.1 Global CRISPR/Cas9 Market Share by Application (2014-2025) 
1.5.2 Biotechnology Companies 
1.5.3 Pharmaceutical Companies 
1.5.4 Academic Institutes 
1.5.5 Research and Development Institutes 
1.6 Study Objectives 
1.7 Years Considered

2 Global Growth Trends 
2.1 CRISPR/Cas9 Market Size 
2.2 CRISPR/Cas9 Growth Trends by Regions 
2.2.1 CRISPR/Cas9 Market Size by Regions (2014-2025) 
2.2.2 CRISPR/Cas9 Market Share by Regions (2014-2019) 
2.3 Industry Trends 
2.3.1 Market Top Trends 
2.3.2 Market Drivers 
2.3.3 Market Opportunities

12 International Players Profiles 
12.1 Caribou Biosciences 
12.1.1 Caribou Biosciences Company Details 
12.1.2 Company Description and Business Overview 
12.1.3 CRISPR/Cas9 Introduction 
12.1.4 Caribou Biosciences Revenue in CRISPR/Cas9 Business (2014-2019) 
12.1.5 Caribou Biosciences Recent Development 
12.2 Integrated DNA Technologies (IDT) 
12.2.1 Integrated DNA Technologies (IDT) Company Details 
12.2.2 Company Description and Business Overview 
12.2.3 CRISPR/Cas9 Introduction 
12.2.4 Integrated DNA Technologies (IDT) Revenue in CRISPR/Cas9 Business (2014-2019) 
12.2.5 Integrated DNA Technologies (IDT) Recent Development 
12.3 CRISPR Therapeutics 
12.3.1 CRISPR Therapeutics Company Details 
12.3.2 Company Description and Business Overview 
12.3.3 CRISPR/Cas9 Introduction 
12.3.4 CRISPR Therapeutics Revenue in CRISPR/Cas9 Business (2014-2019) 
12.3.5 CRISPR Therapeutics Recent Development 
12.4 Merck 
12.4.1 Merck Company Details 
12.4.2 Company Description and Business Overview 
12.4.3 CRISPR/Cas9 Introduction 
12.4.4 Merck Revenue in CRISPR/Cas9 Business (2014-2019) 
12.4.5 Merck Recent Development 
12.5 Mirus Bio 
12.5.1 Mirus Bio Company Details 
12.5.2 Company Description and Business Overview 
12.5.3 CRISPR/Cas9 Introduction 
12.5.4 Mirus Bio Revenue in CRISPR/Cas9 Business (2014-2019) 
12.5.5 Mirus Bio Recent Development 
12.6 Editas Medicine 
12.6.1 Editas Medicine Company Details 
12.6.2 Company Description and Business Overview 
12.6.3 CRISPR/Cas9 Introduction 
12.6.4 Editas Medicine Revenue in CRISPR/Cas9 Business (2014-2019) 
12.6.5 Editas Medicine Recent Development 
12.7 Takara Bio 
12.7.1 Takara Bio Company Details 
12.7.2 Company Description and Business Overview 
12.7.3 CRISPR/Cas9 Introduction 
12.7.4 Takara Bio Revenue in CRISPR/Cas9 Business (2014-2019) 
12.7.5 Takara Bio Recent Development 
12.8 Thermo Fisher Scientific 
12.8.1 Thermo Fisher Scientific Company Details 
12.8.2 Company Description and Business Overview 
12.8.3 CRISPR/Cas9 Introduction 
12.8.4 Thermo Fisher Scientific Revenue in CRISPR/Cas9 Business (2014-2019) 
12.8.5 Thermo Fisher Scientific Recent Development 
12.9 Horizon Discovery Group 
12.9.1 Horizon Discovery Group Company Details 
12.9.2 Company Description and Business Overview 
12.9.3 CRISPR/Cas9 Introduction 
12.9.4 Horizon Discovery Group Revenue in CRISPR/Cas9 Business (2014-2019) 
12.9.5 Horizon Discovery Group Recent Development 
12.10 Intellia Therapeutics 
12.10.1 Intellia Therapeutics Company Details 
12.10.2 Company Description and Business Overview 
12.10.3 CRISPR/Cas9 Introduction 
12.10.4 Intellia Therapeutics Revenue in CRISPR/Cas9 Business (2014-2019) 
12.10.5 Intellia Therapeutics Recent Development 
12.11 Agilent Technologies 
12.12 Cellecta 
12.13 GenScript 
12.14 GeneCopoeia 
12.15 Synthego

Buy Now @




Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Media Contact
Company Name:
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India